Syndax Pharmaceuticals
SNDX
SNDX
218 hedge funds and large institutions have $1.25B invested in Syndax Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 88 increasing their positions, 63 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2.52% more ownership
Funds ownership: 114.85% → 117.37% (+2.5%)
1% more funds holding
Funds holding: 215 → 218 (+3)
3% less capital invested
Capital invested by funds: $1.3B → $1.25B (-$41.1M)
Holders
218
Holding in Top 10
10
Calls
$18.1M
Puts
$7.88M
Top Buyers
| 1 | +$54.6M | |
| 2 | +$37M | |
| 3 | +$29.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$25.7M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$24.6M |
Top Sellers
| 1 | -$59.2M | |
| 2 | -$42.7M | |
| 3 | -$30.1M | |
| 4 |
Goldman Sachs
New York
|
-$28.6M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$23.6M |